Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founders
- Dr. John Hoekman, Ph.D., Dr. Janine Sengstack, Ph.D., Rob Cahill
- Company Description
- Junevity is a biotechnology company developing cell reset therapeutics for longevity. Its RESET platform uses large-scale human data and AI to identify transcription factor targets and repress them with siRNA therapeutics.
- Market
- Healthcare
- Location
-
San Francisco,
California,
USA
- Coinvestors
- Goldcrest Capital, Godfrey Capital
Links